Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response – The TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial-Reference-Cited by-同舟云学术

Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response – The TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial

Published:2013-11-18 Issue:7 Volume:25 Page:506-512
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Dridi Nadia Paarup,Johansson Pär Ingemar,Clemmensen Peter,Stissing Trine,Radu Maria Dumitrela,Qayyum Abbas,Pedersen Frants,Helqvist Steffen,Saunamäki Kari,Kelbæk Henning,Jørgensen Erik,Engstrøm Thomas,Holmvang Lene

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/09537104.2013.845874

Reference40 articles.

1. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting

2. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

4. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

5. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis;Scientific Reports;2020-10-08

2. Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy;CJC Open;2020-05

3. Assessing Prognosis of Acute Coronary Syndrome in Recent Clinical Trials: A Systematic Review;Clinical Medicine & Research;2019-06

4. Platelet reactivity patterns in patients treated with dual antiplatelet therapy;European Journal of Clinical Investigation;2019-03-29

5. Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention;International Journal of Cardiology;2019-01